Skip to main content
UniHealth

Doctor search

Jyothi I Tirumalasetty, MD

Allergy/Immunology · Stanford

NPI 1942257605

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
14
3 carriers
Office
1

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

14 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tirumalasetty’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

14 of 14 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence C164641 · Current

Licensed to practise in California · since 2019 · expires 2027-08-31 · Drexel University College of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$10,658

Medicare paid this office $10,658 for 40 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Short return visit (20+ min)20$2,864$87
New patient visit (45+ min)18$2,585$144
New patient visit (30+ min)14$1,372$98

Who their Medicare patients are

40 Original Medicare patients in 2024. Average age 72 · Women 68% · Health risk score 1.09. Above the middle of the specialty; the typical allergy/ immunology clinician is at 1.

Conditions among them: High blood pressure 53%.

The office billed $55,017, Medicare allowed $13,856 and paid $10,658; for 469 services of 18 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
202440469721.09$55,017$10,658
202232158651.90$30,493$3,247
202186395711.88$123,165$16,078
202047272691.63$62,197$11,032
201956649631.64$28,681$5,068
201852555601.87$28,379$5,786
201749892601.36$32,785$6,405
201649979591.30$31,279$6,586
201544825571.75$23,573$4,861
201449779581.52$26,775$6,633
201393407690.80$12,008$4,926

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2021: 4 services

Original Medicare services billed in 2021
New patient visit (45+ min)35$4,697$134
Return visit (30+ min)22$2,812$104
New patient visit (30+ min)19$1,838$97
Short return visit (20+ min)16$1,530$81

2020: 1 service

Original Medicare services billed in 2020
New patient visit (30+ min)11$978$89

2019: 3 services

Original Medicare services billed in 2019
Return visit (30+ min)15$1,475$61
Short return visit (20+ min)19$959$36
New patient visit (30+ min)15$859$57

2018: 2 services

Original Medicare services billed in 2018
Return visit (30+ min)29$2,306$61
New patient visit (30+ min)11$661$60

2017: 3 services

Original Medicare services billed in 2017
New patient visit (45+ min)13$1,122$86
Short return visit (20+ min)17$863$39
Return visit (30+ min)12$862$62

2016: 4 services

Original Medicare services billed in 2016
Professional service for preparation and provision of 1 or more antigens11$1,943$3
Short return visit (20+ min)16$864$41
New patient visit (30+ min)14$800$57
Return visit (30+ min)11$727$66

2015: 1 service

Original Medicare services billed in 2015
Short return visit (20+ min)14$720$42

2014: 3 services

Original Medicare services billed in 2014
Short return visit (20+ min)21$1,265$40
Professional service for preparation and provision of 1 or more antigens11$1,226$3
Return visit (30+ min)11$991$66

2013: 3 services

Original Medicare services billed in 2013
Professional service for multiple injections of allergen57$941$6
Short return visit (20+ min)12$635$42
Short return visit (20+ min)12$497$41

Medicaid work

$514 in 2020

Medicaid paid $514 for 30 billed services this clinician did in 2020, up to 13 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2020
Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections30$514
Medicaid work by year
202030113$514
2019799417$74,776
2018925527$87,276
See the largest Medicaid services in earlier years

2019

Largest Medicaid services in 2019
ANTIGEN THERAPY SERVICES157$41,839
New patient visit (30+ min)89$13,066
Return visit (30+ min)75$12,199
Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections478$7,672

2018

Largest Medicaid services in 2018
ANTIGEN THERAPY SERVICES276$61,086
Return visit (30+ min)105$14,374
Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections509$8,038
New patient visit (30+ min)20$2,911
Short return visit (20+ min)15$866

Drugs they prescribed that Part D paid

$20,603

Pharmacies billed $20,603 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 87) in 2024. At or below the middle of the specialty; the typical allergy/ immunology clinician is at 0%.

68 generic and 19 brand-name prescriptions · $20,603 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Azelastine25$607$24
Fluticasone Propionate11$139$13

Year by year

Part D prescribing by year
202487250% (0)22%$20,603
2022151440% (0)28%$69,975
2021259660% (0)29%$157,772
2020339720% (0)32%$149,020
2019793810% (0)28%$286,355
2018670740% (0)30%$250,475
2017553720% (0)36%$202,659
201637850None34%$85,880
201536051None35%$95,544
2014314430% (0)47%$70,174
2013111340% (0)67%$23,865

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2022: 5 drugs

Part D drugs prescribed in 2022
Dupixent11$39,245$3,568
Azelastine30$1,616$54
Hydroxyzine11$174$16
Famotidine11$109$10
Montelukast12$98$8

2021: 9 drugs

Part D drugs prescribed in 2021
Xolair23$74,239$3,228
Dupixent13$44,559$3,428
Azelastine28$807$29
Ipratropium12$742$62
Omeprazole21$350$17
Fluticasone Propionate17$333$20
Famotidine22$317$14
Hydroxyzine29$186$6
Levocetirizine Dihydrochloride11$147$13

2020: 8 drugs

Part D drugs prescribed in 2020
Xolair28$98,693$3,525
Breo Ellipta15$5,680$379
Incruse Ellipta14$5,091$364
Epinephrine11$2,815$256
Azelastine32$1,625$51
Fluticasone Propionate50$853$17
Montelukast54$767$14
Levocetirizine Dihydrochloride29$684$24

2019: 18 drugs

Part D drugs prescribed in 2019
Xolair52$175,529$3,376
Nucala15$46,136$3,076
Incruse Ellipta19$6,470$341
Advair Hfa12$5,215$435
Spiriva Respimat11$5,144$468
Breo Ellipta13$4,620$355
Azelastine99$4,589$46
Epinephrine12$2,883$240
Montelukast150$2,396$16
Arnuity Ellipta11$1,971$179
Fluticasone Propionate73$1,529$21
Fluticasone-Salmeterol11$1,261$115
Ventolin Hfa18$1,138$63
Levocetirizine Dihydrochloride86$1,035$12
Ranitidine36$218$6
Hydroxyzine16$169$11
Omeprazole11$166$15
Prednisone27$123$5

2018: 16 drugs

Part D drugs prescribed in 2018
Xolair51$191,283$3,751
Advair Diskus33$18,885$572
Symbicort21$6,684$318
Spiriva Respimat11$4,529$412
Flovent Diskus11$2,936$267
Azelastine47$2,158$46
Montelukast136$2,076$15
Fluticasone Propionate97$1,589$16
Ventolin Hfa22$1,339$61
Fluticasone-Salmeterol11$635$58
Levocetirizine Dihydrochloride62$623$10
Ipratropium24$513$21
Desloratadine12$185$15
Ranitidine36$157$4
Gabapentin12$112$9
Prednisone13$98$8

2017: 12 drugs

Part D drugs prescribed in 2017
Xolair52$155,427$2,989
Advair Diskus25$12,403$496
Azelastine55$3,437$62
Epinephrine12$3,133$261
Flovent Diskus11$2,582$235
Ventolin Hfa26$1,964$76
Montelukast87$1,423$16
Fluticasone Propionate100$1,376$14
Proair Hfa17$998$59
Levocetirizine Dihydrochloride34$362$11
Ranitidine22$227$10
Prednisone15$66$4

2016: 10 drugs

Part D drugs prescribed in 2016
Xolair12$50,715$4,226
Epipen 2-Pak19$10,847$571
Advair Diskus14$5,812$415
Pataday12$2,284$190
Fluticasone Propionate90$1,451$16
Montelukast80$1,394$17
Ventolin Hfa12$1,158$96
Azelastine31$809$26
Ipratropium12$209$17
Ranitidine17$196$12

2015: 8 drugs

Part D drugs prescribed in 2015
Xolair11$62,855$5,714
Advair Diskus15$7,987$532
Epipen 2-Pak11$5,360$487
Montelukast85$1,587$19
Azelastine29$1,426$49
Fluticasone Propionate76$1,210$16
Proair Hfa22$1,147$52
Desloratadine13$517$40

2014: 8 drugs

Part D drugs prescribed in 2014
Xolair15$37,128$2,475
Advair Diskus32$13,593$425
Symbicort14$4,383$313
Proair Hfa24$1,203$50
Azelastine17$1,177$69
Fluticasone Propionate49$1,114$23
Montelukast59$1,040$18
Ventolin Hfa11$849$77

2013: 2 drugs

Part D drugs prescribed in 2013
Advair Diskus16$5,712$357
Montelukast11$549$50

Money from drug and device companies

$245 in 2025

Industry payments by year
202523None$245
202411None$31

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
GenzymeWayrilz$191
2 payments
  • Meals · 2025-05-20 · $82
  • Meals for Wayrilz · 2025-05-20 · $109
Genentech USAXolair$54
1 payment
  • Meals for Xolair · 2025-05-20 · $54
See all 3 published payments
Every published payment
Genentech USAMeals · 2025-05-20Xolair$54
GenzymeMeals · 2025-05-20None$82
GenzymeMeals · 2025-05-20Wayrilz$109
See earlier years (2024)

2024: $31

Payments by company in 2024
Novartis PharmaceuticalsNone$31
1 payment
  • Meals · 2024-02-26 · $31

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1942257605
Licence
CA C164641California C164641: Current · expires 2027-08-31
Trained
Drexel University College of Medicine, 2001
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207K00000X (207K00000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2006-05-28
NPI last updated
2024-04-17
NPI record certified
2024-04-17

This is when the NPI record was last certified, not a medical board exam.